Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.34973 | 13 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.33719 | 14 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.33675 | 13 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.29066 | 14 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.29314 | 14 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.47376 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.49908 | 20 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.31201 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.31383 | 14 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.32334 | 13 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.32061 | 13 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.30442 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.32387 | 13 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.32688 | 13 |